Bupropion Therapy
Research results from Mt. Sinai Hospital update knowledge of bupropion therapy
Published in Hospital Law Weekly, March 11th, 2010
"The objectives of this study were as follows: to probe whether bupropion disrupts LI; to compare its efficacy to the effects of GBR12783 (specific DA uptake inhibitor) and to amphetamine (DA releaser); to test if antipsychotics would reverse LI deficits induced by bupropion, GBR12783, and amphetamine; and to probe if rolipram (phosphodiesterase-4 inhibitor), which increases cyclic AMP (cAMP)...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
Source: Hospital Law Weekly (2010-03-11)
More Articles from Hospital Law Weekly
- COBRAGuard Inc.
COBRAGuard Partners With THA to Offer Texas Hospitals COBRA Relief - Consumer Watchdog
Internal Anthem Blue Cross/WellPoint Document: Only Patients Who 'Push Back' Get Covered Out of State Liver Transplants - Consumer Watchdog
WellPoint/Blue Cross Liver Transplant Denial Trial Begins Today, Illustrates Need for Toughening of White House Reform Plan - Crohn Disease Epidemiology
Data on Crohn disease epidemiology detailed by researchers at Universitat Autonoma de Barcelona - Fujitsu Frontech North America Inc.
Fujitsu PalmSecure Authentication Solution Integrated Into Patient Registration System at Holy Name Hospital - Gallup
New Gallup Poll Quantifies U.S. Physician Opinions on the Scope of Defensive Medicine Practices - More from this issue of Hospital Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
